glp-1 medication metairie Hair Loss and Medications Medical Weight Loss Education Materials

This advanced formula combines two potent ingredients, Glutathione and Arbutin, to promote brighter, more even-toned skin

CMD takes into consideration an individuals age, skin condition, aesthetic goals, previous cosmetic procedures, recovery needs, and lifestyle factors

Research use only, not for human consumption

Promotes skin whitening by inhibiting hyperpigmentation and melanin synthesis, while also reducing irritation

Furthermore, in January 2025, the FDA approved semaglutide (Ozempic ) for reducing the risk of kidney failure and disease progression in patients with diabetes and chronic kidney disease (CKD), making it the first GLP-1 agent indicated for the treatment of CKD (Perkovic et al., 2024)